Results 151 to 160 of about 984,029 (267)
Appearance of basal cell carcinoma on untreated capillary malformation. [PDF]
Buchroithner C +5 more
europepmc +1 more source
Giant basal cell cancer. A case of giant basis cell cancer which developed on the left buttock.
Ikuko Shimatani +3 more
openalex +2 more sources
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert +13 more
wiley +1 more source
Beyond the skin - metastatic basal cell carcinoma in the stomach: A case report. [PDF]
Ahmadi S, Joarder I, Jowhari F.
europepmc +1 more source
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source
Multicentric basal cell carcinoma of the penis and scrotum: a rare case report. [PDF]
Filosa FG +10 more
europepmc +1 more source
Influence of the cardiomyocyte niche on cell-based heart repair
Benjamin W. Lee
openalex +1 more source
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu +18 more
wiley +1 more source

